Assessing deterioration using impairment and functional outcome measures in chronic inflammatory demyelinating polyneuropathy: A post‐hoc analysis of the immunoglobulin overtreatment in CIDP trial

It is unclear whether frequently used cutoff values for outcome measures defining minimal clinically important differences (MCIDs) can accurately identify meaningful deterioration in chronic inflammatory demyelinating polyneuropathy (CIDP). We used data from the immunoglobulin overtreatment in CIDP...

Descripción completa

Detalles Bibliográficos
Autores principales: van Veen, Robin, Wieske, Luuk, Lucke, Ilse, Adrichem, Max E., Merkies, Ingemar S. J., van Schaik, Ivo N., Eftimov, Filip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2022
Materias:
Research Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321849/
https://www.ncbi.nlm.nih.gov/pubmed/35507446
http://dx.doi.org/10.1111/jns.12497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321849/
https://www.ncbi.nlm.nih.gov/pubmed/35507446
http://dx.doi.org/10.1111/jns.12497

Ejemplares similares